Thus, in the PTEN-mut glioma, CLCF1, AEBP1, and OS9, which are significantly associated with survival time, may induce glioma progression and are critical targets for diagnosis, prognosis prediction, and treatment, giving therapeutic recommendations to glioma with mutant PTEN. This evidence concerns the gene CLCF1 and central nervous system cancer.